The estimated Net Worth of Jo Natauri is at least $619 millió dollars as of 12 July 2021. Ms. Natauri owns over 300 units of Avantor stock worth over $15,006,523 and over the last 5 years she sold AVTR stock worth over $604,489,455. In addition, she makes $0 as Director at Avantor.
Sign up
Ms. Natauri AVTR stock SEC Form 4 insiders trading
Jo has made over 5 trades of the Avantor stock since 2019, according to the Form 4 filled with the SEC. Most recently she bought 300 units of AVTR stock worth $10,899 on 12 July 2021.
The largest trade she's ever made was selling 15,397,005 units of Avantor stock on 21 August 2020 worth over $300,395,568. On average, Jo trades about 5,345,377 units every 131 days since 2019. As of 12 July 2021 she still owns at least 557,656 units of Avantor stock.
You can see the complete history of Ms. Natauri stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jo Natauri biography
Jo Natauri is Director of the company. Ms. Natauri has served on our board since November 2018. Ms. Natauri is a Managing Director and the global head of Healthcare Investing within the Merchant Banking Division (“MBD”) of Goldman Sachs, a global investment banking, securities and investment management firm, a position she has held since May 2018. In her current role, Ms. Natauri oversees a portfolio of investments and serves on the boards, or as an observer on the boards, of several MBD portfolio companies. Prior to assuming her current role in MBD, Ms. Natauri was an investment banker with Goldman Sachs for 12 years, where she led coverage of large cap companies in healthcare and other industries. She was named managing director in 2008 and partner in 2012. Ms. Natauri serves on the board of Safe Horizon, the nation’s leading victim assistance organization. Ms. Natauri earned a B.A. in economics and biology from the University of Virginia.
How old is Jo Natauri?
Jo Natauri is 42, she's been the Director of Avantor since 2018. There are 29 older and 1 younger executives at Avantor. The oldest executive at Avantor Inc. is Rajiv Gupta, 74, who is the Chairman of the Board.
What's Jo Natauri's mailing address?
Jo's mailing address filed with the SEC is C/O GOLDMAN SACHS & CO. LLC, 200 WEST STREET, NEW YORK, NY, 10282.
Insiders trading at Avantor
Over the last 6 years, insiders at Avantor have traded over $3,149,576,044 worth of Avantor stock and bought 27,800 units worth $584,024 . The most active insiders traders include Mountain Investments Iii, L..., Jo Natauri és Sachs & Co. Llc Stone Bridg.... On average, Avantor executives and independent directors trade stock every 21 days with the average trade being worth of $48,107,115. The most recent stock trade was executed by Steven W Eck on 5 September 2024, trading 3,525 units of AVTR stock currently worth $88,337.
What does Avantor do?
based in center valley, pa (usa), avantor performance materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the j.t.baker®, macron fine chemicals™, rankem™, benesphera™, and poch™ brands. avantor products are used in a wide range of industries. our life sciences solutions are used in pharmaceutical production, laboratory research for academic, industry and quality control, and in medical lab testing. our electronics solutions are used in the manufacturing of semiconductors. for additional information please visit www.avantormaterials.com
What does Avantor's logo look like?
Complete history of Ms. Natauri stock trades at Avantor
Avantor executives and stock owners
Avantor executives and other stock owners filed with the SEC include:
-
Michael Stubblefield,
President, Chief Executive Officer, Director -
Thomas Szlosek,
Chief Financial Officer, Executive Vice President -
Michael Stubblefield,
Pres, CEO & Director -
Gerard Brophy,
Executive Vice President - Biopharma Production -
Devashish Ohri,
Executive Vice President - AMEA -
Frederic Vanderhaegen,
Executive Vice President - Americas and Europe -
Thomas A. Szlosek,
Exec. VP & CFO -
Frederic Vanderhaegen,
Exec. VP of Americas & Europe -
Dr. Gerald Brophy Ph.D.,
Exec. VP of Biopharma Production -
Michael Wondrasch,
Exec. VP & Chief Information Officer -
Rajiv Gupta,
Chairman of the Board -
Jonathan Peacock,
Independent Director -
Christi Shaw,
Independent Director -
Rakesh Sachdev,
Independent Director -
Juan Andres,
Independent Director -
Gregory Summe,
Independent Director -
Michael Severino,
Independent Director -
Jo Natauri,
Director -
Andre Moura,
Director -
Matthew Holt,
Director -
Steven Eck,
Senior Vice President, Chief Accounting Officer -
Mark Murray,
Executive Vice President of the Biomaterials and Advanced Technologies Platform -
Sven Henrichwark,
Executive Vice President of APAC -
Tanya Foxe,
Executive Vice President - Global Operations and Supply Chain -
Christophe Couturier,
Executive Vice President - Services, Strategy and Business Transformation -
James Bramwell,
Executive Vice President - Strategic Partners -
Justin Miller,
Executive Vice President, General Counsel, Secretary -
Michael Wondrasch,
Executive Vice President, Chief Information Officer -
Eric McAllister,
Chief Human Resource Officer, Executive Vice President -
Allison K. Hosak,
Sr. VP of Global Communications & Brand -
Justin M. Miller Esq.,
Exec. VP, Gen. Counsel & Sec. -
Tommy J. Thomas CPA,
VP of Investor Relations -
Steven W. Eck,
Sr. VP, Corp. Controller & Chief Accounting Officer -
Sheri Lewis,
Exec. VP, Global Operations & Supply Chain -
Lan Kang,
Director -
John Carethers,
Director -
Sachs & Co. Llc Stone Bridg...,
-
Sachs & Co. Llc Stone Bridg...,
-
Sheri Lewis,
EVP, Global Ops & Supply Chain -
Mountain Investments Iii, L...,
-
Mala Murthy,
Director -
Brittany Hankamer,
EVP, Chief HR Officer -
Randy Lee Stone,
EVP, Laboratory Solutions -
Corey Walker,
President Laboratory Solutions -
Ashish Kulkarni,
See Remarks -
Sachs & Co. Llcgoldman Sach...,
-
Meghan Henson,
EVP, Chief HR Officer -
Thomas Connolly,
Director -
Joseph R Massaro,
Director -
Kitty Sahin,
EVP, Strategy&Corp Development -
Claudius Sokenu,
EVP, Chief Legal & Compliance -
R. Brent Jones,
EVP, Chief Financial Officer -
Benoit Gourdier,
EVP, Biopharma Production